Cargando…
What is New in Pharmacologic Therapy for Cardiac Resuscitation?
Antiarrhythmic therapy can be a critical component of cardiac resuscitation. Therapies in this area have seen little advance in the last decade. Bretylium, a very old drug, has been reintroduced for ventricular tachycardia/ventricular fibrillation (VT/VF) therapy. There are still important questions...
Autores principales: | Somberg, John, Molnar, Janos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239592/ https://www.ncbi.nlm.nih.gov/pubmed/32494323 http://dx.doi.org/10.14740/cr1058 |
Ejemplares similares
-
The Efficacy of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin: A Randomized Clinical Trial
por: Bryan, Nathan S., et al.
Publicado: (2023) -
Pharmacological Therapy of Osteoporosis: What’s New?
por: Iolascon, Giovanni, et al.
Publicado: (2020) -
Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion
por: Somberg, John C., et al.
Publicado: (2020) -
Glucocorticoids as an Emerging Pharmacologic Agent for Cardiopulmonary Resuscitation
por: Varvarousi, Giolanda, et al.
Publicado: (2014) -
We Need More COVID Therapies
por: Somberg, John
Publicado: (2023)